Anti-Human CD274 Recombinant Antibody(Atezolizumab)
-
产品编号
YR1354
-
别名
科研级 Atezolizumab ( 阿特利珠单抗 ), Anti-CD274 Recombinant Antibody, Research Grade Atezolizumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Atezolizumab ( 阿特利珠单抗 ), Anti-CD274 Recombinant Antibody, Research Grade Atezolizumab |
Catalog Number | YR1354 |
Molecular Name | Atezolizumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), small cell lung cancer (SCLC), and hepatocellular carcinoma (HCC). It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). |
CAS Number | 1380723-44-3 |
Application | ELISA, IHC, IF, IP, FCM |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Molecular Weight | 144.59 kDa |
Target | CD274[Homo sapiens] |